Celularity, Inc. (CELU) vs Sangamo Therapeutics, Inc. (SGMOQ)
- Celularity, Inc. CELU 1.25 −6.02%
- Sangamo Therapeutics, Inc. SGMOQ 0.11 −21.43%
Celularity, Inc. and Sangamo Therapeutics, Inc. are both Biotechnology companies. Celularity, Inc. and Sangamo Therapeutics, Inc. are of similar size ($43.2M and $41.9M). Sangamo Therapeutics, Inc. grew revenue faster over the last twelve months: −45.8% against −62.8%. Sangamo Therapeutics, Inc. has the higher net margin (−356.9% vs −375.9%) and the higher return on invested capital (0.00% vs −695.7%). Across the 17 metrics below, Sangamo Therapeutics, Inc. leads on 9 and Celularity, Inc. on 8.
Valuation
Profitability
| Metric | CELU | SGMOQ | Biotechnology median |
|---|---|---|---|
| Gross margin | 5.26% | 100.00% | 65.16% |
| Operating margin | (321.32%) | (357.55%) | 0.00% |
| Net margin | (375.89%) | (356.89%) | 0.00% |
| Free cash flow margin | (46.46%) | (261.76%) | 0.00% |
| Return on equity | 349.83% | 1,755.72% | (56.36%) |
| Return on assets | (62.45%) | (168.79%) | (48.04%) |
| Return on invested capital | (695.71%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack